Product Information
AU1235 is an experimental antibiotic that is a potent inhibitor of the mycobacterial cell wall synthesis. It prevents mycolic acid-containing lipids from being incorporated into the cell wall, which leads to inhibition of mycobacterium growth. The target enzymes for AU1235 are unknown, but it has been shown to inhibit protein synthesis and uptake in mycobacterial cells. The clinical development of AU1235 as a drug for tuberculosis is currently ongoing.
6-Fluoro-3-indoxyl-beta-D-galactopyranoside
Rifapentine is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch
Chemical properties
Technical inquiry about: 3D-NDC78086 AU1235
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
